The clinical performance is complex and often involves multiple systems. Early identification and standardization of the diagnosis is essential for improving the prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely regimens based on changes in disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of chest lumps associated with anti-synthesis syndrome. The platform serves China International Medical Service System, a team of authoritative experts at home and abroad in the field of autoimmune and rheumatic immunity, to provide the following services to patients: 1. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.